Biocon Biologics Refinances ₹9,100 crore Debt with Bonds and Syndicated Facility

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Biocon Biologics refinances ₹9,100 crore debt through ₹6,600 crore bonds and a syndicated debt facility. The refinancing is set to improve liquidity and drive reinvestment into its biosimilars pipeline.

Biocon Biologics Limited (BBL), a subsidiary of Biocon, has successfully priced its ₹6,600 crore senior secured notes, due in 2029, with a 6.67% coupon. The bond issuance, backed by robust collateral, is part of a broader strategy to refinance existing ₹9,100 crore debt, enhancing the company’s liquidity.

Biocon Limited

Trade

390.753.04 (0.78 %)

Updated - 24 February 2026
392.00day high
DAY HIGH
385.05day low
DAY LOW
2179315
VOLUME (BSE)

In addition to the bond, BBL has secured a new syndicated debt facility through a commitment agreement. The proceeds will be used to strengthen its capital structure, allowing Biocon Biologics to reinvest in its biosimilars pipeline and drive long-term growth. CEO Shreehas Tambe stated that this refinancing would also diversify the company’s investor base by attracting global healthcare investors.

As of 12:45 PM on October 3, 2024, Biocon Ltd’s share price is trading at ₹359.50, reflecting a 3.01% decline. The share price has been closely watched as this refinancing is expected to boost confidence in the company’s financial flexibility. This bond issuance is scheduled to settle on October 9, subject to customary conditions.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Published Date : 03 Oct 2024

Disclaimer :

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|